Overview

Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury

Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
To investigate the effect of Bevacizumab on asymptomatic radiotherapy-induced brain injury patients with head and neck cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Treatments:
Bevacizumab